血清25-羟基维生素D缺乏是老年人步态缓慢的危险因素吗?来自英国老龄化纵向研究的证据。

IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Mariane Marques Luiz PhD, Roberta de Oliveira Máximo PhD, Aline Fernanda de Souza PhD, Thales Batista de Souza MSc, Sara Souza Lima MSc, Leticia Coelho Silveira MSc, Thaís Barros Pereira da Silva MSc, Andrew Steptoe PhD, Cesar de Oliveira PhD, Tiago da Silva Alexandre PhD
{"title":"血清25-羟基维生素D缺乏是老年人步态缓慢的危险因素吗?来自英国老龄化纵向研究的证据。","authors":"Mariane Marques Luiz PhD,&nbsp;Roberta de Oliveira Máximo PhD,&nbsp;Aline Fernanda de Souza PhD,&nbsp;Thales Batista de Souza MSc,&nbsp;Sara Souza Lima MSc,&nbsp;Leticia Coelho Silveira MSc,&nbsp;Thaís Barros Pereira da Silva MSc,&nbsp;Andrew Steptoe PhD,&nbsp;Cesar de Oliveira PhD,&nbsp;Tiago da Silva Alexandre PhD","doi":"10.1111/dom.16317","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>Cross-sectional studies demonstrate an association between low serum levels of vitamin D and slower gait speed in older individuals. However, longitudinal studies remain inconclusive. This study investigates whether vitamin D deficiency and insufficiency are risk factors for the incidence of slowness.</p>\n </section>\n \n <section>\n \n <h3> Materials and Methods</h3>\n \n <p>A total of 2815 participants from the English Longitudinal Study of Ageing (ELSA), aged ≥60 years and with a baseline gait speed &gt;0.8 m/s, were followed for six years. Baseline serum levels of vitamin D [25(OH)D] were categorized as “sufficiency” (&gt;50 nmol/L), “insufficiency” (&gt;30 and ≤50 nmol/L) or “deficiency” (≤30 nmol/L). Gait speed was reassessed at four and six years of follow-up to identify incident cases of slowness (walking speed ≤0.8 m/s). A Poisson regression model, adjusted for sociodemographic, behavioural and clinical characteristics at baseline, was conducted to determine the association between serum 25(OH)D levels and the risk of slowness.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The incidence densities of slowness per 1000 person-years were 67.4 (95% CI: 60.93–74.64) for sufficiency, 76.7 (95% CI: 68.30–86.22) for insufficiency and 90.7 (95% CI: 78.46–104.92) for deficiency. Serum 25(OH)D deficiency was associated with a 22% increase in the risk of slowness (IRR: 1.22; 95% CI: 1.01–1.49) compared with serum 25(OH)D sufficiency. No significant association was observed for serum 25(OH)D insufficiency.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Serum 25(OH)D deficiency is a risk factor for the incidence of slowness in older individuals, suggesting that maintaining sufficient 25(OH)D levels could be a strategic approach to minimise long-term mobility impairment.</p>\n </section>\n </div>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":"27 6","pages":"3104-3112"},"PeriodicalIF":5.4000,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dom.16317","citationCount":"0","resultStr":"{\"title\":\"Is serum 25-hydroxyvitamin D deficiency a risk factor for the incidence of slow gait speed in older individuals? Evidence from the English longitudinal study of ageing\",\"authors\":\"Mariane Marques Luiz PhD,&nbsp;Roberta de Oliveira Máximo PhD,&nbsp;Aline Fernanda de Souza PhD,&nbsp;Thales Batista de Souza MSc,&nbsp;Sara Souza Lima MSc,&nbsp;Leticia Coelho Silveira MSc,&nbsp;Thaís Barros Pereira da Silva MSc,&nbsp;Andrew Steptoe PhD,&nbsp;Cesar de Oliveira PhD,&nbsp;Tiago da Silva Alexandre PhD\",\"doi\":\"10.1111/dom.16317\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Aims</h3>\\n \\n <p>Cross-sectional studies demonstrate an association between low serum levels of vitamin D and slower gait speed in older individuals. However, longitudinal studies remain inconclusive. This study investigates whether vitamin D deficiency and insufficiency are risk factors for the incidence of slowness.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Materials and Methods</h3>\\n \\n <p>A total of 2815 participants from the English Longitudinal Study of Ageing (ELSA), aged ≥60 years and with a baseline gait speed &gt;0.8 m/s, were followed for six years. Baseline serum levels of vitamin D [25(OH)D] were categorized as “sufficiency” (&gt;50 nmol/L), “insufficiency” (&gt;30 and ≤50 nmol/L) or “deficiency” (≤30 nmol/L). Gait speed was reassessed at four and six years of follow-up to identify incident cases of slowness (walking speed ≤0.8 m/s). A Poisson regression model, adjusted for sociodemographic, behavioural and clinical characteristics at baseline, was conducted to determine the association between serum 25(OH)D levels and the risk of slowness.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>The incidence densities of slowness per 1000 person-years were 67.4 (95% CI: 60.93–74.64) for sufficiency, 76.7 (95% CI: 68.30–86.22) for insufficiency and 90.7 (95% CI: 78.46–104.92) for deficiency. Serum 25(OH)D deficiency was associated with a 22% increase in the risk of slowness (IRR: 1.22; 95% CI: 1.01–1.49) compared with serum 25(OH)D sufficiency. No significant association was observed for serum 25(OH)D insufficiency.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Serum 25(OH)D deficiency is a risk factor for the incidence of slowness in older individuals, suggesting that maintaining sufficient 25(OH)D levels could be a strategic approach to minimise long-term mobility impairment.</p>\\n </section>\\n </div>\",\"PeriodicalId\":158,\"journal\":{\"name\":\"Diabetes, Obesity & Metabolism\",\"volume\":\"27 6\",\"pages\":\"3104-3112\"},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2025-03-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dom.16317\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Obesity & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/dom.16317\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/dom.16317","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:横断面研究表明,老年人血清维生素D水平低与步态速度慢之间存在关联。然而,纵向研究仍然没有定论。本研究探讨维生素D缺乏和不足是否为发生缓慢的危险因素。材料与方法:共2815名来自英国老龄化纵向研究(ELSA)的参与者,年龄≥60岁,基线步态速度>.8 m/s,随访6年。维生素D [25(OH)D]的基线血清水平被分类为“充足”(bbb50 nmol/L)、“不足”(bbb30和≤50 nmol/L)或“缺乏”(≤30 nmol/L)。在4年和6年的随访中重新评估步态速度,以确定缓慢的事件(步行速度≤0.8 m/s)。采用泊松回归模型,对基线时的社会人口学、行为和临床特征进行调整,以确定血清25(OH)D水平与慢速风险之间的关系。结果:充足率为67.4 (95% CI: 60.93-74.64),不足率为76.7 (95% CI: 68.30-86.22),不足率为90.7 (95% CI: 78.46-104.92)。血清25(OH)D缺乏与缓慢风险增加22%相关(IRR: 1.22;95% CI: 1.01-1.49)与血清25(OH)D充足率比较。血清25(OH)D不足无显著相关性。结论:血清25(OH)D缺乏是老年人运动迟缓的一个危险因素,提示维持足够的25(OH)D水平可能是减少长期行动障碍的一种策略方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Is serum 25-hydroxyvitamin D deficiency a risk factor for the incidence of slow gait speed in older individuals? Evidence from the English longitudinal study of ageing

Is serum 25-hydroxyvitamin D deficiency a risk factor for the incidence of slow gait speed in older individuals? Evidence from the English longitudinal study of ageing

Aims

Cross-sectional studies demonstrate an association between low serum levels of vitamin D and slower gait speed in older individuals. However, longitudinal studies remain inconclusive. This study investigates whether vitamin D deficiency and insufficiency are risk factors for the incidence of slowness.

Materials and Methods

A total of 2815 participants from the English Longitudinal Study of Ageing (ELSA), aged ≥60 years and with a baseline gait speed >0.8 m/s, were followed for six years. Baseline serum levels of vitamin D [25(OH)D] were categorized as “sufficiency” (>50 nmol/L), “insufficiency” (>30 and ≤50 nmol/L) or “deficiency” (≤30 nmol/L). Gait speed was reassessed at four and six years of follow-up to identify incident cases of slowness (walking speed ≤0.8 m/s). A Poisson regression model, adjusted for sociodemographic, behavioural and clinical characteristics at baseline, was conducted to determine the association between serum 25(OH)D levels and the risk of slowness.

Results

The incidence densities of slowness per 1000 person-years were 67.4 (95% CI: 60.93–74.64) for sufficiency, 76.7 (95% CI: 68.30–86.22) for insufficiency and 90.7 (95% CI: 78.46–104.92) for deficiency. Serum 25(OH)D deficiency was associated with a 22% increase in the risk of slowness (IRR: 1.22; 95% CI: 1.01–1.49) compared with serum 25(OH)D sufficiency. No significant association was observed for serum 25(OH)D insufficiency.

Conclusions

Serum 25(OH)D deficiency is a risk factor for the incidence of slowness in older individuals, suggesting that maintaining sufficient 25(OH)D levels could be a strategic approach to minimise long-term mobility impairment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信